114 related articles for article (PubMed ID: 34230124)
1. Calcipotriol Enhances Efficacy of Imatinib and Nilotinib on Cells Derived from Plexiform Neurofibroma.
Zhao Y; Yan M; Mautner V; Smeets R; Gosau M; Kluwe L; Friedrich RE
Anticancer Res; 2021 Jul; 41(7):3293-3298. PubMed ID: 34230124
[TBL] [Abstract][Full Text] [Related]
2. Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.
Wei J; Freytag M; Schober Y; Nockher WA; Mautner VF; Friedrich RE; Manley PW; Kluwe L; Kurtz A
PLoS One; 2014; 9(10):e107760. PubMed ID: 25340526
[TBL] [Abstract][Full Text] [Related]
3. Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model.
Demestre M; Herzberg J; Holtkamp N; Hagel C; Reuss D; Friedrich RE; Kluwe L; Von Deimling A; Mautner VF; Kurtz A
J Neurooncol; 2010 May; 98(1):11-9. PubMed ID: 19921098
[TBL] [Abstract][Full Text] [Related]
4. Propranolol Specifically Suppresses the Viability of Tumorous Schwann Cells Derived from Plexiform Neurofibromas
Zou Z; Guo L; Mautner V; Smeets R; Kiuwe L; Friedrich RE
In Vivo; 2020; 34(3):1031-1036. PubMed ID: 32354889
[TBL] [Abstract][Full Text] [Related]
5. Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.
Varin J; Poulain L; Hivelin M; Nusbaum P; Hubas A; Laurendeau I; Lantieri L; Wolkenstein P; Vidaud M; Pasmant E; Chapuis N; Parfait B
Oncotarget; 2016 Jun; 7(24):35753-35767. PubMed ID: 26840085
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and selectivity of nilotinib on NF1-associated tumors in vitro.
Jiang W; Schnabel C; Spyra M; Mautner VF; Friedrich RE; Hagel C; Manley PW; Kluwe L
J Neurooncol; 2014 Jan; 116(2):231-6. PubMed ID: 24173684
[TBL] [Abstract][Full Text] [Related]
7. Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.
Robertson KA; Nalepa G; Yang FC; Bowers DC; Ho CY; Hutchins GD; Croop JM; Vik TA; Denne SC; Parada LF; Hingtgen CM; Walsh LE; Yu M; Pradhan KR; Edwards-Brown MK; Cohen MD; Fletcher JW; Travers JB; Staser KW; Lee MW; Sherman MR; Davis CJ; Miller LC; Ingram DA; Clapp DW
Lancet Oncol; 2012 Dec; 13(12):1218-24. PubMed ID: 23099009
[TBL] [Abstract][Full Text] [Related]
8. Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1.
Armstrong AE; Rhodes SD; Smith A; Chen S; Bessler W; Ferguson MJ; Jiang L; Li X; Yuan J; Yang X; Yang FC; Robertson KA; Ingram DA; Blakeley JO; Clapp DW
Pediatr Blood Cancer; 2020 Aug; 67(8):e28372. PubMed ID: 32459399
[TBL] [Abstract][Full Text] [Related]
9. Increased nuclear translation of YAP might act as a potential therapeutic target for NF1-related plexiform neurofibroma.
Liu JL; You YH; Tian ZW; Xiao M; Zheng JW; Wang YA; Du Z
Int J Med Sci; 2021; 18(9):2008-2016. PubMed ID: 33850471
[TBL] [Abstract][Full Text] [Related]
10. Modeling tumors of the peripheral nervous system associated with Neurofibromatosis type 1: Reprogramming plexiform neurofibroma cells.
Mazuelas H; Carrió M; Serra E
Stem Cell Res; 2020 Dec; 49():102068. PubMed ID: 33160273
[TBL] [Abstract][Full Text] [Related]
11. Treatment for plexiform neurofibromas in patients with NF1.
Ardern-Holmes SL; North KN
Lancet Oncol; 2012 Dec; 13(12):1175-6. PubMed ID: 23099008
[No Abstract] [Full Text] [Related]
12. Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.
Yang FC; Ingram DA; Chen S; Zhu Y; Yuan J; Li X; Yang X; Knowles S; Horn W; Li Y; Zhang S; Yang Y; Vakili ST; Yu M; Burns D; Robertson K; Hutchins G; Parada LF; Clapp DW
Cell; 2008 Oct; 135(3):437-48. PubMed ID: 18984156
[TBL] [Abstract][Full Text] [Related]
13. Schwann cell derived pleiotrophin stimulates fibroblast for proliferation and excessive collagen deposition in plexiform neurofibroma.
Tian Z; Du Z; Bai G; Gong Q; You Y; Xu G; Liu J; Xiao M; Wang Y; He Y
Cancer Gene Ther; 2024 Apr; 31(4):627-640. PubMed ID: 38302728
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.
Carrió M; Mazuelas H; Richaud-Patin Y; Gel B; Terribas E; Rosas I; Jimenez-Delgado S; Biayna J; Vendredy L; Blanco I; Castellanos E; Lázaro C; Raya Á; Serra E
Stem Cell Reports; 2019 Feb; 12(2):411-426. PubMed ID: 30713041
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological and genomic profiling of neurofibromatosis type 1 plexiform neurofibroma-derived schwann cells.
Ferrer M; Gosline SJC; Stathis M; Zhang X; Guo X; Guha R; Ryman DA; Wallace MR; Kasch-Semenza L; Hao H; Ingersoll R; Mohr D; Thomas C; Verma S; Guinney J; Blakeley JO
Sci Data; 2018 Jun; 5():180106. PubMed ID: 29893754
[TBL] [Abstract][Full Text] [Related]
16. Modeling iPSC-derived human neurofibroma-like tumors in mice uncovers the heterogeneity of Schwann cells within plexiform neurofibromas.
Mazuelas H; Magallón-Lorenz M; Fernández-Rodríguez J; Uriarte-Arrazola I; Richaud-Patin Y; Terribas E; Villanueva A; Castellanos E; Blanco I; Raya Á; Chojnacki J; Heyn H; Romagosa C; Lázaro C; Gel B; Carrió M; Serra E
Cell Rep; 2022 Feb; 38(7):110385. PubMed ID: 35172160
[TBL] [Abstract][Full Text] [Related]
17. Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.
Yang FC; Chen S; Clegg T; Li X; Morgan T; Estwick SA; Yuan J; Khalaf W; Burgin S; Travers J; Parada LF; Ingram DA; Clapp DW
Hum Mol Genet; 2006 Aug; 15(16):2421-37. PubMed ID: 16835260
[TBL] [Abstract][Full Text] [Related]
18. Marrow signal changes observed in follow-up whole-body MRI studies in children and young adults with neurofibromatosis type 1 treated with imatinib mesylate (Gleevec) for plexiform neurofibromas.
Karmazyn B; Cohen MD; Jennings SG; Robertson KA
Pediatr Radiol; 2012 Oct; 42(10):1218-22. PubMed ID: 22722872
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform Neurofibromas.
Ferguson MJ; Rhodes SD; Jiang L; Li X; Yuan J; Yang X; Zhang S; Vakili ST; Territo P; Hutchins G; Yang FC; Ingram DA; Clapp DW; Chen S
Pediatr Blood Cancer; 2016 Feb; 63(2):206-13. PubMed ID: 26375012
[TBL] [Abstract][Full Text] [Related]
20. STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma.
Fletcher JS; Springer MG; Choi K; Jousma E; Rizvi TA; Dombi E; Kim MO; Wu J; Ratner N
Oncogene; 2019 Apr; 38(15):2876-2884. PubMed ID: 30542122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
